MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2013, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2013-06-20
DOI
10.1155/2013/370526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease
- (2012) Candan Depboylu et al. EXPERIMENTAL NEUROLOGY
- Matrix metalloproteinase-3 in the central nervous system: a look on the bright side
- (2012) Inge Van Hove et al. JOURNAL OF NEUROCHEMISTRY
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
- (2012) Valerio Pisani et al. Journal of Neuroinflammation
- Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control
- (2011) Laure Chagniel et al. BEHAVIOURAL BRAIN RESEARCH
- The role of neuroinflammation on the pathogenesis of Parkinson's disease
- (2011) Young-Cheul Chung et al. BMB Reports
- A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP
- (2011) Hyo Jin Son et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
- (2011) Dong-Hee Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
- (2011) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson's Disease
- (2011) S. H. Huh et al. JOURNAL OF IMMUNOLOGY
- An Aberrant Cerebellar Development in Mice Lacking Matrix Metalloproteinase-3
- (2011) Inge Van Hove et al. MOLECULAR NEUROBIOLOGY
- Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation
- (2011) Young C. Chung et al. NEUROPHARMACOLOGY
- Matrix Metalloproteinase-3 Is Increased and Participates in Neuronal Apoptotic Signaling Downstream of Caspase-12 during Endoplasmic Reticulum Stress
- (2010) Eun-Mee Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson's Disease
- (2010) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- Role of matrix metalloproteinase-3 in neurodegeneration
- (2010) Eun-Mee Kim et al. JOURNAL OF NEUROCHEMISTRY
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
- (2009) Sehee Kim et al. JOURNAL OF ENDOCRINOLOGY
- Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease
- (2009) Yin Xia Chao et al. JOURNAL OF NEUROIMMUNOLOGY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons
- (2009) Sung Tae Kim et al. NEUROCHEMISTRY INTERNATIONAL
- Doxycycline is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
- (2009) Yuri Cho et al. NEUROTOXICITY RESEARCH
- Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation
- (2009) Minho Moon et al. NEUROTOXICITY RESEARCH
- The blood-brain barrier in brain homeostasis and neurological diseases
- (2008) Nicolas Weiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- CD4+ T cells mediate cytotoxicity in neurodegenerative diseases
- (2008) Stanley H. Appel JOURNAL OF CLINICAL INVESTIGATION
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
- (2008) Vanessa Brochard et al. JOURNAL OF CLINICAL INVESTIGATION
- Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum
- (2008) Xuesong Chen et al. JOURNAL OF NEUROCHEMISTRY
- A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
- (2008) Dong Hee Choi et al. JOURNAL OF NEUROCHEMISTRY
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started